CHG Combined With Venetoclax and Azacytidine in Newly Diagnosed AML
Clinical trial NCT06470841 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06470841
- Sponsor
- Navy General Hospital, Beijing
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-20
- Primary completion
- 2027-12-01
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.